Orthotopic liver transplantation in HBs-antigen positive patients: short-term results.

[1]  R. Tur-kaspa,et al.  Beneficial effect of lamivudine in recurrent hepatitis B after liver transplantation. , 1997, Transplantation.

[2]  B. C. Wong,et al.  Lamivudine is effective in suppressing hepatitis B virus DNA in Chinese hepatitis B surface antigen carriers: A placebo‐controlled trial , 1997, Hepatology.

[3]  D. Tyrrell,et al.  Efficacy of lamivudine in chronic hepatitis B patients with active viral replication and decompensated cirrhosis undergoing liver transplantation. , 1996, Transplantation.

[4]  A. Burroughs,et al.  Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis , 1996, The Lancet.

[5]  R. Tubiana,et al.  Effects of Lamivudine on Replication of Hepatitis B Virus in HIV-Infected Men , 1996, Annals of Internal Medicine.

[6]  T. W. Kwon,et al.  Unlimited-term passive immunoprophylaxis after liver transplantation in HBsAg-positive patients. , 1996, Transplantation proceedings.

[7]  A. Karrenbeld,et al.  Hepatitis B-associated liver cirrhosis as an indication for liver transplantation. , 1995, Scandinavian journal of gastroenterology. Supplement.

[8]  W. Bechstein,et al.  Long-term follow-up of hepatitis B virus-infected recipients after orthotopic liver transplantation. , 1994, Transplantation.

[9]  S. Davies,et al.  Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications. , 1992, Journal of hepatology.

[10]  C. Wittekind,et al.  Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization. , 1991, Journal of hepatology.

[11]  M. Rizzetto,et al.  Liver transplantation in carriers of the HBsAg. , 1991, Journal of hepatology.

[12]  D. Samuel,et al.  Passive immunoprophylaxis after liver transplantation in HBsAg-positive patients , 1991, The Lancet.

[13]  R. Freeman,et al.  Serologic and DNA follow-up data from HBsAg-positive patients treated with orthotopic liver transplantation. , 1991, Transplantation.

[14]  D. Samuel,et al.  HBV infection after liver transplantation in HBsAg positive patients: experience with long-term immunoprophylaxis. , 1991, Transplantation proceedings.

[15]  T. Starzl,et al.  Recurrent hepatitis B in liver allograft recipients. Differentiation between viral hepatitis B and rejection. , 1986, The American journal of pathology.